Collaboration in Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Collaboration in Clinical Trials in Brazil

Collaboration in Clinical Trials in Brazil – Research Studies in South America

Clinical trials are pivotal in advancing medical knowledge and driving improvements in healthcare. In Brazil, a country with a vibrant healthcare landscape, collaboration among stakeholders plays a crucial role in unleashing the potential of clinical trials.

This blog explores the significance of collaboration in clinical trials in Brazil, shedding light on the benefits it offers to researchers, patients, and the healthcare system. By fostering strong partnerships and promoting synergy, Brazil has the opportunity to emerge as a global leader in cutting-edge clinical research, accelerating medical breakthroughs, and revolutionizing patient care.

The Value of Collaboration in Clinical Trials

Collaboration is paramount to the success of clinical trials, as it involves the collective efforts of various stakeholders, including pharmaceutical companies, research institutions, regulatory bodies, healthcare professionals, and patient communities. In Brazil, with its diverse healthcare landscape, collaboration becomes even more essential.

By working together, these stakeholders can leverage their resources, expertise, and knowledge, leading to enhanced trial quality and efficiency. Collaboration facilitates knowledge sharing, reduces duplication of efforts, improves patient recruitment and retention, and expedites the translation of research findings into practical applications.

Furthermore, collaboration ensures adherence to ethical and regulatory standards, promotes patient safety, and strengthens the overall integrity of the clinical trial process.

Strengthening Industry-Academia Partnerships

An integral aspect of collaboration in clinical trials involves forging strong partnerships between the pharmaceutical industry and academic institutions. Such partnerships allow for the fusion of academic expertise, access to diverse patient populations, and cutting-edge research facilities with the financial resources, drug development knowledge, and industry experience brought by pharmaceutical companies.

By joining forces, researchers can conduct robust clinical trials, while pharmaceutical companies gain valuable insights and local expertise. These collaborations foster knowledge exchange, skill development, and capacity building, nurturing a skilled workforce capable of driving clinical research forward in Brazil.

Collaboration in Clinical Trials in Brazil

Collaboration in Clinical Trials in Brazil

Collaboration in Clinical Trials in Brazil

Collaborative Engagement with Regulatory Authorities

Collaboration with regulatory authorities is critical to ensure adherence to ethical and legal standards in clinical trials. In Brazil, the National Health Surveillance Agency (ANVISA) oversees the regulation and approval of clinical trials. Engaging in open dialogue and cooperation with regulatory bodies allows researchers and industry stakeholders to gain a comprehensive understanding of requirements, streamlining the approval process.

Transparent communication channels facilitate the exchange of information, promote regulatory compliance, and enable regulatory authorities to stay abreast of scientific advancements and international best practices. This collaborative approach informs and enhances the regulatory framework, making it more efficient and adaptable to emerging medical technologies.

Empowering Patient Participation

Active engagement of patients is a crucial element of collaboration in clinical trials. By involving patients and their communities, their rights, welfare, and perspectives are respected. Patient participation enhances trial recruitment, retention, and trial design, ultimately improving the quality and relevance of clinical research in Brazil. Initiatives promoting patient advocacy, education, and empowerment play a vital role in fostering collaboration.

Patient associations, support groups, and digital platforms provide platforms for patients to share their experiences, contribute to trial design, and offer valuable feedback to researchers. Involving patients throughout the trial process ensures a patient-centered approach, leading to more effective treatments and better healthcare outcomes.


Collaboration serves as a driving force behind the progress of medical research and the advancement of healthcare outcomes through clinical trials. In Brazil, by fostering collaboration among stakeholders, including pharmaceutical companies, academic institutions, regulatory bodies, and patients, the country can harness its potential to become a global frontrunner in cutting-edge clinical research.

The benefits of collaboration include improved trial efficiency, accelerated development of innovative treatments, enhanced patient recruitment and retention, strengthened regulatory compliance, and patient-centered care. By nurturing strong collaborations and promoting a culture of cooperation, Brazil can unlock new possibilities in clinical research, revolutionize patient care, and contribute to global medical advancements.

Collaboration in Clinical Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Collaboration in Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Collaboration in Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Collaboration in Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Collaboration in Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Collaboration in Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Collaboration in Clinical Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Collaboration in Clinical Trials in Brazil

The Cohortias Team

Collaboration in Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Collaboration in Clinical Trials in Brazil

Network & Partnerships